Endovascular Articles
-
Microbot Medical Enhances its Scientific Advisory Board (SAB) with its Newest Member Dr. Vincent Vidal
Prominent France based interventional radiologist to leverage his expertise to assist the Company to achieve its future objective for the LIBERTY® Robotic System HINGHAM, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), which continues to build a network of global leaders in the endovascular interventional space for the LIBERTY® Robotic System, today ...
-
Micromate™ Case Report: Robot-Guided Type II Endoleak Embolization
Micromate™ Case Report series presents real cases performed by the physicians currently using the world’s smallest robot for percutaneous procedures. Today, we join Drs. Gerlig Widmann and Martin Freund, Interventional Radiologists at the Tirol Kliniken, for a robot-guided type II endoleak embolization. Clinical Context Patient’s profile: Male patient, previously subjected ...
-
Cost-Effectiveness of Percutaneous Deep Vein Arterialization for Patients with No-Option Chronic Limb-Threatening Ischemia: an Exploratory Analysis Based on the PROMISE I Study
Abstract Background. As the most advanced stage of peripheral arterial disease (PAD), chronic limb-threatening ischemia (CLTI) is associated with a high risk of lower-limb loss and mortality. Percutaneous deep vein arterialization (pDVA) is a promising new treatment alternative for CLTI patients who cannot be treated with conventional revascularization techniques. Our study objective was to ...
-
The New Guidelines For Interventional Oncology - And How Micromate™ Seamlessly Fits Into Them
Interventional Oncology, the 4th pillar of modern cancer care Until the late 90s, modern cancer care consisted of three pillars of treatment: surgery (through tumor resection), radiation therapy, and chemotherapy. These pillars address tumors directly, removing or destroying lesions. Although immunotherapy specialists devised ingenious ways to use the patients’ own immune system to better ...
-
How One Smart MedTech Company is Leveraging Innovation to Save the Lives and Limbs of VTE Patients
Medical device start-up companies must focus on innovation, regulatory compliance, efficient processes and prudent financial management in order to survive. Smart MedTech companies prioritize their funding to only support innovation which will result in new products that fulfill significant unmet clinical needs over the long-term. Thrombolex, a relatively new entrant into the MedTech sector, is a ...
-
‘First In-Heart Microcomputer,’ EVAR Suture-Delivery Catheter Named Top CRT Innovations
The “world’s first in-heart microcomputer” and an endovascular aortic repair (EVAR) suture-delivery catheter were recognized Saturday as the best innovations of CRT 2021 Virtual. The judges chose the V-LAP implantable microcomputer (Vectorious Medical Technologies Ltd.), presented by Tal Hasin, MD, of Shaare Zedek Medical Center, Jerusalem. CRT audience members voted for ...
By Vectorious
-
Results Published from FIH Study of Thrombolex’s Bashir Endovascular Catheter
February 9, 2021—Findings from the first-in-human (FIH) study assessing the safety and feasibility of the Bashir endovascular catheter (BEC; Thrombolex, Inc.) for the treatment of acute intermediate-risk pulmonary embolism (PE) were published by Akhilesh K. Sista, MD, et al in Circulation: Cardiovascular Intervention (2021;14). The BEC is a pharmacomechanical device designed to enhance ...
-
Cleveland Clinic: First Case Completed in Feasibility Study of Non-Radiation-Based EVAR Navigation Platform
MOTION study will quantify new technology’s impact on radiation exposure In December, Cleveland Clinic vascular surgeons successfully completed the first surgical case in the MOTION clinical trial of a new non-radiation-based surgical navigation platform for endovascular aortic interventions. The trial is a feasibility study of the Intra-Operative Positioning System (IOPS™) from ...
-
The Evolving Role of Percutaneous Deep Venous Arterialization
The increasing incidence of peripheral artery disease (PAD) is occurring globally as populations age and rates of diabetes, obesity, and renal disease increase.1-3 Although most of these patients have no symptoms, when the disease progresses to its most advanced form, chronic limb-threatening ischemia (CLTI), there is a significant risk for limb loss. Despite the fact that our revascularization ...
-
A Revolution of EVAR Imaging Technologies
Endovascular aneurysm repair (EVAR) has dramatically evolved over the past 2 decades—from relatively simple tubular endografts to extraordinarily complex branched endografts that allow endovascular coverage from the sinotubular junction through the iliac bifurcation. With this increasing complexity of repairs, parallel improvements in imaging and navigation technologies have ensued. These ...
-
MIMICS-2 at 1 year: 3D stent meets safety & effectiveness goals
The TCTMD reports on Timothy Sullivan's presentation at the International Symposium on Endovascular Therapy. In terms of 12-month primary patency, the strategy of "natural swirling flow is an alternative to antiproliferative drugs," the researcher says. ...
-
Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Metaanalysis of Efficacy and Safety Outcomes
Background: Arteriovenous fistulae are the currently recommended gold standard vascular access modality for haemodialysis because of their prolonged patency, improved durability, and low risk of infection for those that mature. However, notable disadvantages are observed in terms of protracted maturation time, associated high rates of catheter use, and substantial abandonment rates. The aim of ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you